PHARMA FOCUS//Cannabis FOCUS
A golden perspective on medical marijuana
Although the medicinal Cannabis industry is still in its infancy, it’s experiencing unprecedented levels of growth and investment. CanbiGold is positioned to positively impact this rapid expansion with its expertise in the design, modification and manufacture of unique modular growth units for the industry. By Abby Vorster
A
ccording to a new report by Grand View Research, the size of the global legal Cannabis market is expected to reach
US$66.3 billion by the end of 2025. It’s anticipated to expand at a CAGR of 23.9 percent during the forecast period with increasing legalisation and the use of marijuana in medical applications driving this growth. Based on the extensive range of
A graphical representation of a CanbiGold fortress
therapeutic benefits of Cannabis, ranging from pain and stress relief to effectively managing cancer, dementia and Alzheimer’s, CBD has made its way
significant portion of land, while R&D and the
development of CBD-infused tampons to
into health supplements, oils, cosmetics
production of 99 percent CBD products take
assist women with menstrual pain and
and foodstuffs.
place in its Cape Town based laboratory,
cramping. Working with brand owner, Foxy
under pharmaceutical conditions.
Pink, the two companies developed the
Leon van der Linde, CEO of
unique tampon, which is said to provide
Major global investment One of the first South African businesses
CanbiGold, says the past 12 months
users with a soothing, tension-melting
to capitalise on the ‘green gold rush’ is
have been significant for the business.
effect, delivering 10mg of CBD directly to
CanbiGold. Based in the Western Cape,
In November 2019, the company took
the area where it’s needed most.
CanbiGold is a vertically integrated,
part in The Cannabis Expo at the Sandon
private company that specialises in the
Convention Centre where it secured a
include blending African and Cannabis
cultivation and production of medicinal
whopping R600 million deal with Koomo
extracts together in nutraceutical
cannabis and related products utilising
Capital, an investment business from
formulations to help curb the symptoms of
unique patented intellectual property.
the US, and Canngea, Australia’s only
various ailments, including insomnia, IBS,
It has also developed unique modular
medical cannabis licensed contract
crohn’s disease and colon cancer.
growth units, which meet international
manufacturing organisation.
Additional R&D efforts of the company
CanbiGold is also researching alternative ways to medicate with CBD
ISO standards, allowing new or current ventures to scale up on growing,
Innovation and R&D
such as inhalation, electronic cigarettes
vegetation, flowering and drying modules
CanbiGold is also making significant
and absorption via the vaginal tract. •
as necessary.
inroads in Cannabis-based nutraceutical
CanbiGold’s cultivation occurs in the
and health and wellness product
Maseru Special Economic Zone in Lesotho
development. Van der Linde says the
where the company has secured a
company played a pivotal role in the
CanbiGold – www.canbigold.com
P C Review | FEBRUARY 2020 |
21
